Search results for:
polatuzumab vedotin
polatuzumab vedotin
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Polatuzumab Vedotin (Polivy) |
POWDER FOR INJECTION, INTRAVENOUS |
30 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Polatuzumab Vedotin (Polivy) |
POWDER FOR INJECTION, INTRAVENOUS |
140 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Apr. 19, 2023
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of polatuzumab vedotin injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions